Advertisement

May 28, 2013

Teleflex Announces CE Mark Approval for Arrow GPSCath Balloon Dilatation Catheters

May 29, 2013—Teleflex Incorporated (Limerick, PA) announced that it has received CE Mark approval to market the company's Arrow GPSCath balloon dilatation catheters in the European Union. The Arrow GPSCath catheter is designed as a dual-function device that incorporates the company's VisioValve injection system, which enables interventionists to perform high-pressure angioplasty and inject physician-specified fluids, such as contrast, while maintaining guidewire position.

Advertisement


May 30, 2013

Medtronic Gains FDA Approval for Endurant II Aorto-Uni-Iliac Device, 510(k) Clearance for Sentrant Introducer Sheath

May 28, 2013

FDA Clears Aptus's 28-mm Tip Reach Heli-FX Guide for Wide-Neck AAA Treatment